Royal Bank of Canada’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-499
Closed 7804
2023
Q3
$0 Sell
499
-432
-46% -$115 ﹤0.01% 7837
2023
Q2
$0 Buy
931
+926
+18,520% +$262 ﹤0.01% 7851
2023
Q1
$0 Hold
5
﹤0.01% 7674
2022
Q4
$0 Sell
5
-219
-98% -$220 ﹤0.01% 7951
2022
Q3
$0 Buy
+224
New +$396 ﹤0.01% 8054
2022
Q2
Sell
-1,537
Closed -$12K 7895
2022
Q1
$12K Sell
1,537
-3,715
-71% -$30.8K ﹤0.01% 6889
2021
Q4
$73K Buy
5,252
+3,157
+151% +$62.2K ﹤0.01% 6153
2021
Q3
$54K Buy
2,095
+412
+24% +$13.1K ﹤0.01% 6120
2021
Q2
$77K Sell
1,683
-19
-1% -$899 ﹤0.01% 5762
2021
Q1
$75K Buy
1,702
+1,671
+5,390% +$81.3K ﹤0.01% 5642
2020
Q4
$1K Buy
+31
New +$983 ﹤0.01% 6993

Other funds holding AMTI

Royal Bank of Canada's AMTI Position: Q4 2023 in Review

Royal Bank of Canada sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 499 shares.

Royal Bank of Canada first reported a position in AMTI in Q4 2020 and held it in 11 quarters. The position peaked at $77K in Q2 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • Royal Bank of Canada reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 499 Applied Molecular Transport Inc. Common Stock shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Royal Bank of Canada's Applied Molecular Transport Inc. Common Stock position peaked at $77K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.